OAR 855-021-0010
Continuing Pharmacy Education
(1)
In this rule the terms below have the meanings given:(a)
“Patient Safety” means procedures and processes that ensure that the correct patient receives the correct drug in the correct dose, and is counseled appropriately.(b)
“Medication error prevention” means procedures and processes to prevent and avoid adverse events and to ensure that the correct patient receives the correct drug in the correct dose.(2)
A continuing pharmacy education program means classes of post graduate studies, informal study group participation, institutes, seminars, lectures, conferences, workshops, extension study, correspondence courses, teaching, planned and professional meetings, self study courses, cassette or audio visual tape/slides or materials, and other self instruction units:(a)
A program shall consist of therapeutics, or pharmacy and drug law or other aspects of health care. A minimum of at least two hours of continuing education credit must be earned in the area of pharmacy and drug law. A minimum of two hours of continuing education credit must be earned in the area of patient safety or medication error prevention.(b)
Programs shall provide for examinations or other methods of evaluation to assure satisfactory completion by participants.(c)
The person or persons who are to instruct or who are responsible for the delivery or content of the program shall be qualified in the subject matter by education and experience.(3)
Continuing pharmacy education programs shall be approved by the Board of Pharmacy. Application for approval shall be made on and in accordance with forms established by the Board. The forms shall require information relating to:(a)
Name of provider or sponsor;(b)
Type of program offered;(c)
Description of subject matter;(d)
Number of contact hours offered;(e)
Total number of contact hours in therapeutics or pharmacy and drug law or other aspects of health care;(f)
Method of determining satisfactory completion of program;(g)
Dates and location of program;(h)
Name and qualification of instructors or other persons responsible for the delivery or content of the program.(4)
CE programs are not required to carry approval of American Council on Pharmaceutical Education (ACPE). Programs presented by providers approved by the American Council on Pharmacy Education (ACPE) are generally accepted, however, the Board reserves the right to determine the number of hours allowed or to disapprove such programs.(5)
Providers shall provide attendees with proof of attendance that shows the date and number of contact hours provided. Providers must maintain attendance lists for three years.(6)
Continuing pharmacy education credit accumulated in excess of the required 30 contact hours for biennial license renewal cannot be carried forward.(7)
A maximum of 20 contact hours (2.0 CEU) may be earned in any licensing cycle by preparing and presenting CE programs. Pharmacists presenting CE programs may earn one contact hour (0.1 CEU) for preparation time of one hour or more, plus credit for the actual contact hour time of the presentation. A pharmacist must show content of the course, and a description of the intended audience (e.g., pharmacists, physicians, nurses). Public service programs, such as presentations to school children or service clubs, are not eligible for continuing education credit.(8)
Pharmacists taking post graduate studies applicable to graduate or professional degrees may submit the course syllabus and evidence of satisfactory completion of the course for continuing education credit approval by the Board.(9)
The Board may approve up to 26 contact hours of CE credit for pharmacists who have successfully completed nationally certified Disease State Management courses.(10)
Board members or staff may attend CE programs for the purpose of evaluating content, format and appropriateness of material for Continuing Pharmacy Education credit. Subsequent programs by CE providers whose current programs are deemed deficient by on-site evaluation may be required to obtain prior approval by the Board. The Board will provide feedback to CE providers regarding evaluated CE presentations.
Source:
Rule 855-021-0010 — Continuing Pharmacy Education, https://secure.sos.state.or.us/oard/view.action?ruleNumber=855-021-0010.